Return To Blog
Global to host cannabis and medical marijuana CME Conference in Denver, October 4, 2019
By John McCormick - July 26, 2019
Global Education Group is pleased to announce that we will be hosting a CME / CE conference on October 4, 2019, in Denver, CO. CMP 2019 focuses on the entire endocannabinoid system, medical cannabis, and marijuana.
Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP 2019) is an educational and accredited CME / CE live conference which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policy and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry.
CMP Symposium 2019 is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medical cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.
• Alan M. Lembitz, MD - Chief Medical Officer - COPIC
• Brad Roberts, MD - Emergency Medicine Physician - Parkview Medical Center
• Deann Zenisek, JD - Attorney - Conklin Cardone & Rutberg, PC
• Doris Gundersen, MD - Medical Director - Colorado Physician Health Program
• Karen Randall, DO - Emergency Medicine Physician - Southern Colorado Emergency Medicine Associates
• Kenneth P. Finn, MD - President and Founder - Springs Rehabilitation, P.C.
• Leeann Blaskowski, NNP - Neonatal Nurse Practitioner - St. Francis Medical Center
• Lisa Robin - Chief Advocacy Officer - Federation of State Medical Boards
• Phillip Drum, PharmD - Pharmacy Consultant - Kaiser Permanente
• Shauna Callan, PhD - Co Founder and Director of Scientific Content - Headwaters Communications
• Stephen Ziegler, JD, PhD - Professor Emeritus of Public Policy - Purdue University
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live CME activity for a maximum of 7.5 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Global Education Group designates this continuing education activity for 7.5 contact hour(s) (0.75 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number 0530-0000-19-101-L04-P, 0530-0000-19-092-L01-P, 0530-0000-19-093-L03-P, 0530-0000-19-094-L03-P, 0530-0000-19-095-L03-P,
0530-0000-19-096-L04-P, 0530-0000-19-097-L04-P, 0530-0000-19-098-L04-P, 0530-0000-19-099-L04-P, 0530-0000-19-100-L04-P).
This is a knowledge-based activity
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
Instructions to Receive Credit
In order to receive CME/CE and/or COPIC Points you must complete a post test/evaluation form after the event concludes. No credit will be given without a fully completed post evaluation form. A link to this will be emailed to your registered email address.
Fee & Refund/Cancellation Policy
There is a fee for this educational activity.
A refund will be issued for cancellations on or before 9/4/2019 less a $79 administration fee. No refunds will be permitted after 9/4/2019. Registrations may, however, be transferred to another individual or to a future meeting.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
• Alan M. Lembitz, MD – Nothing to disclose
• Brad Roberts, MD – Nothing to disclose
• Deann Zenisek, JD – Nothing to disclose
• Doris Gundersen, MD – Nothing to disclose
• Karen Randall, DO – Nothing to disclose
• Kenneth P. Finn, MD – Nothing to disclose
• Leeann Blaskowski, NNP – Nothing to disclose
• Lisa Robin – Nothing to disclose
• Phillip Drum, PharmD – Nothing to disclose
• Shauna Callan, PhD – Nothing to disclose
• Stephen Ziegler, JD, PhD – Nothing to disclose
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
• Andrea Funk – Nothing to disclose
• Ashley Cann – Nothing to disclose
• Carlos Ferreira – Nothing to disclose
• Esther Langmack, MD – Nothing to disclose
• Liddy Knight – Nothing to disclose
• Lindsay Borvansky, PT, DPT, ATC – Nothing to disclose
• Matthew Callan, PhD – Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To learn more about the conference visit us online at www.cmpsymposium.com.
Â
Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP 2019) is an educational and accredited CME / CE live conference which, due to its multidisciplinary nature, will highlight the endocannabinoid system, its management, and relevant policy and laws. The faculty will speak from their expertise as physicians and lawyers in the marijuana industry.
CMP Symposium 2019 is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medical cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.
Overall, the participants of Controversies in Medicine and Policy Symposium: The State of Evidence for Cannabinoids - Scientific and Regulatory Issues (CMP 2019) will benefit from learning about recent and emerging clinical practices involving the endocannabinoid system.
Regardless of your role in the medical community, CMP Symposium 2019 is for you, and an excellent way to earn CME credits while learning about the emerging fields of medical marijuana, cannabis, and the endocannabinoid system.
Accreditation Information
This activity is provided by Global Education Group.
This activity is approved for 2 COPIC Points.
Target Audience
This educational activity is designed to meet the needs of primary care practitioners inclusive of: physicians, nurse practitioners, physician assistants, and pharmacists who have interest in the emerging field of cannabis.
Statement of Need/Program Overview
This symposium is designed to be an exchange of ideas between participants and the expert faculty and will provide lectures on scientific and regulatory issues, including recent research, policy, diagnostics, and therapeutic advances. Participants will learn about medicinal cannabis and evidence-based policies to consider implementing in their daily practice and be informed about the possibilities for continuous medical education. Participants will also learn about clinical trial designs, how to become successful investigators of co-operative research groups, and how to be better informed about patient support.
Learning Objectives
After completing this activity, participants should be able to:
- Outline the endocannabinoid system.
- Review the current evidence-based indications for the use of cannabis.
- Review the effects of cannabis use, including physiological effects.
- Describe the Colorado experience after mass commercialization of cannabis for medical purposes.
- Review Colorado Medical Board Rules, Regulations and Policies impact on cannabinoid use.
- Recognize FDA policy and regulation of CBD-containing products for therapeutic use.
- Explain the interaction of cannabis and opioids.
- Review the known risks for psychiatric complications related to cannabinoid use.
- Discuss recent studies of cannabinoids in the treatment of psychiatric disorders.
- Discuss what is known about cannabinoid exposure in developing brains.
- Identify major epidemiological trends associated with cannabis legalization.
- Describe common emergency department presentations related to cannabis use.
- Identify best practices for discussing cannabinoid use in Colorado’s legal and regulatory climate.
• Alan M. Lembitz, MD - Chief Medical Officer - COPIC
• Brad Roberts, MD - Emergency Medicine Physician - Parkview Medical Center
• Deann Zenisek, JD - Attorney - Conklin Cardone & Rutberg, PC
• Doris Gundersen, MD - Medical Director - Colorado Physician Health Program
• Karen Randall, DO - Emergency Medicine Physician - Southern Colorado Emergency Medicine Associates
• Kenneth P. Finn, MD - President and Founder - Springs Rehabilitation, P.C.
• Leeann Blaskowski, NNP - Neonatal Nurse Practitioner - St. Francis Medical Center
• Lisa Robin - Chief Advocacy Officer - Federation of State Medical Boards
• Phillip Drum, PharmD - Pharmacy Consultant - Kaiser Permanente
• Shauna Callan, PhD - Co Founder and Director of Scientific Content - Headwaters Communications
• Stephen Ziegler, JD, PhD - Professor Emeritus of Public Policy - Purdue University
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live CME activity for a maximum of 7.5 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Global Education Group designates this continuing education activity for 7.5 contact hour(s) (0.75 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number 0530-0000-19-101-L04-P, 0530-0000-19-092-L01-P, 0530-0000-19-093-L03-P, 0530-0000-19-094-L03-P, 0530-0000-19-095-L03-P,
0530-0000-19-096-L04-P, 0530-0000-19-097-L04-P, 0530-0000-19-098-L04-P, 0530-0000-19-099-L04-P, 0530-0000-19-100-L04-P).
This is a knowledge-based activity
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com
Instructions to Receive Credit
In order to receive CME/CE and/or COPIC Points you must complete a post test/evaluation form after the event concludes. No credit will be given without a fully completed post evaluation form. A link to this will be emailed to your registered email address.
Fee & Refund/Cancellation Policy
There is a fee for this educational activity.
A refund will be issued for cancellations on or before 9/4/2019 less a $79 administration fee. No refunds will be permitted after 9/4/2019. Registrations may, however, be transferred to another individual or to a future meeting.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
• Alan M. Lembitz, MD – Nothing to disclose
• Brad Roberts, MD – Nothing to disclose
• Deann Zenisek, JD – Nothing to disclose
• Doris Gundersen, MD – Nothing to disclose
• Karen Randall, DO – Nothing to disclose
• Kenneth P. Finn, MD – Nothing to disclose
• Leeann Blaskowski, NNP – Nothing to disclose
• Lisa Robin – Nothing to disclose
• Phillip Drum, PharmD – Nothing to disclose
• Shauna Callan, PhD – Nothing to disclose
• Stephen Ziegler, JD, PhD – Nothing to disclose
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
• Andrea Funk – Nothing to disclose
• Ashley Cann – Nothing to disclose
• Carlos Ferreira – Nothing to disclose
• Esther Langmack, MD – Nothing to disclose
• Liddy Knight – Nothing to disclose
• Lindsay Borvansky, PT, DPT, ATC – Nothing to disclose
• Matthew Callan, PhD – Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To learn more about the conference visit us online at www.cmpsymposium.com.
Â